What is the duration of the effect of urinary acidifying agents on the plasma concentrations and clinical activity of lisdexamfetamine (Elvanse) and dexamfetamine (Amfexa) after the acidifying agent is administered? | Rounds What is the duration of the effect of urinary acidifying agents on the plasma concentrations and clinical activity of lisdexamfetamine (Elvanse) and dexamfetamine (Amfexa) after the acidifying agent is administered? | Rounds
Loading...

What is the duration of the effect of urinary acidifying agents on the plasma concentrations and clinical activity of lisdexamfetamine (Elvanse) and dexamfetamine (Amfexa) after the acidifying agent is administered?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 · View editorial policy

Effect of Urinary Acidifying Agents on Amphetamine Plasma Concentrations and Activity

Urinary acidifying agents (eg, ammonium chloride, sodium acid phosphate, methenamine salts) are expected to lower circulating amphetamine concentrations and reduce clinical efficacy by increasing renal elimination of the ionized (more protonated) drug. [1] Amfexa (dexamfetamine) SmPC

Timing After Acidifying Agent Administration

Urine acidification from an ammonium-chloride acid load is typically monitored with urine pH testing using hourly urine collections for about 2 to 8 hours after administration in clinical testing protocols. [2]

This 2–8 hour window is the best directly supported human time frame for the period during which urinary pH is actively altered, which is the mechanistic basis for increased amphetamine urinary excretion during that interval. [2] [3]

Lisdexamfetamine (Elvanse/Vyvanse) Specific Duration

Lisdexamfetamine is a prodrug of dextroamphetamine that is rapidly converted to active d-amphetamine after absorption, so any interaction effect is expected to manifest during the period when urinary pH is acidified and renal excretion of amphetamine is increased. [4] [3]

No lisdexamfetamine–urinary-acidifier study provides a precisely defined “effect duration after acidifying agent dosing” in terms of time to return to baseline plasma concentrations or time to return of clinical activity. [1]

Dexamfetamine (Amfexa) Specific Duration

Dexamfetamine labeling includes the pharmacologic interaction concept that urinary acidifying agents increase urinary excretion of ionized amphetamine, which can lower blood concentrations and efficacy. Amfexa SmPC

No published human dexamfetamine–specific time course is provided that defines how long after ammonium-chloride (or other urinary acidifiers) plasma concentrations remain reduced or clinical activity remains diminished. Amfexa SmPC

Clinical Activity Duration Expectation

Given the lack of direct lisdexamfetamine- or dexamfetamine-specific time-course data, the interaction is most consistently framed as a temporary interaction while urinary pH is actively acidified, which is supported by monitoring practices in ammonium-chloride urine acidification testing (~2–8 hours). Medscape (urine acidification test timing) [3]

Practical Interpretation for Elvanse vs Amfexa

For both lisdexamfetamine and dexamfetamine, the best-supported estimate for the period during which urinary acidifying agents are likely to lower amphetamine plasma exposure and reduce effect is the interval in which urinary pH remains acidified after dosing, approximately 2 to 8 hours for ammonium-chloride–type acid-loading regimens. [2] [3] [1] Amfexa SmPC

Related Questions